Skip to main content
    The obesity clinic
    Menu closed
    Mounjaro
    Tirzepatide
    GLP-1
    +2

    Published 7 January 2026 · 9 minutes reading time

    Mounjaro (tirzepatide) - complete guide 2026

    Everything you need to know about Mounjaro: how it works, expected results, side effects, cost, and how to get a prescription in Sweden.

    Mounjaro tirzepatide - complete guide for weight treatment in Sweden

    Quick answer

    Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors and can lead to significant weight loss when combined with lifestyle support. It is prescription-only and requires medical assessment.

    DD

    Dr. Dorél Lehrer

    Licensed Physician

    Medical Director at Viktenheten
    Experienced in medical weight management

    Verifierad av Socialstyrelsen

    Medicinskt granskad: 7 January 2026

    Mounjaro is a dual-agonist medication (GLP-1 + GIP) that can deliver substantial weight loss under medical supervision.

    How Mounjaro works

    Tirzepatide activates GLP-1 and GIP receptors to improve satiety, reduce appetite, and support metabolic control.

    Results and expectations

    Clinical trials show significant weight loss when combined with lifestyle changes. Results vary by dose and adherence.

    Access in Sweden

    Mounjaro requires a prescription and medical assessment to ensure safety and appropriate dosing.

    Ready for the Next Step?

    Our physicians help you develop a safe and evidence-based plan for medical weight treatment.

    Book a Mounjaro assessment

    Related Articles

    View all articles
    7 January 2026

    Mounjaro vs Wegovy - which is right for you?

    Read article
    7 January 2026

    GLP-1 medication comparison 2026: Wegovy, Mounjaro, Rybelsus, Ozempic

    Read article
    7 January 2026

    Wegovy in Sweden - how to get a prescription (2026)

    Read article

    Discover more

    Part of Curevo Health

    Viktenheten is part of Curevo Health, Sweden’s digital specialist care platform.